Journal of Clinical Oncology | 2019

Direct evidence of a clonal and tumor-directed T cell response to prostate cancer brachytherapy.

 
 
 
 
 
 
 
 
 
 
 
 
 

Abstract


22Background: We characterised the immune response in human prostate cancer (PC) to high dose rate brachytherapy (HDRBT) using serial pre- and post-HDRBT biopsies. Methods: Prostate biopsies and pe...

Volume 37
Pages 22-22
DOI 10.1200/JCO.2019.37.7_SUPPL.22
Language English
Journal Journal of Clinical Oncology

Full Text